NASDAQ:MENS Jyong Biotech Q4 2025 Earnings Report $2.18 +0.15 (+7.39%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$2.18 +0.00 (+0.05%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Jyong Biotech EPS ResultsActual EPS-$0.02Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AJyong Biotech Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AJyong Biotech Announcement DetailsQuarterQ4 2025Date5/15/2026TimeBefore Market OpensConference Call DateFriday, May 15, 2026Conference Call Time7:00AM ETConference Call ResourcesAnnual Report (20-F)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(20-F) Jyong Biotech Earnings HeadlinesJyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal RoadshowSeptember 3, 2026 | globenewswire.comJyong Biotech Ltd. Ordinary Shares (MENS)July 29, 2026 | nasdaq.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. | Porter & Company (Ad)Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing PartnershipsJuly 23, 2026 | globenewswire.comJyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International ConventionJuly 2, 2026 | globenewswire.comJyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live InterviewMay 29, 2026 | globenewswire.comSee More Jyong Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Jyong Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jyong Biotech and other key companies, straight to your email. Email Address About Jyong BiotechJyong Biotech (NASDAQ:MENS) Limited is a clinical-stage biopharmaceutical company focused on developing and commercializing botanical drug products. The company’s research is centered on plant-derived therapies for urological conditions, including disorders affecting the prostate and urinary system. Its product development activities have primarily targeted benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate that can cause urinary symptoms, as well as other prostate-related conditions. Jyong Biotech’s portfolio includes botanical drug candidates and related products intended to address unmet needs in urological care. The company is headquartered in China and conducts its research and development activities there. Jyong Biotech is listed on the Nasdaq Capital Market under the symbol MENS. Publicly available information provides limited detail about its broader geographic operations and executive leadership.View Jyong Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market Share Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
